Quotient Sciences Header

Quotient Sciences Header

X

Find Hematology Drugs in Phase III Clinical Development in INDIA

Filters

×

FILTER:

filter

News Type

filter

Company

filter

Product Type

filter

Deal Size

filter

Upfront Payment

Active Filter(s):

Filters

Reset Filter

All Developments

Product Type

Companies

Zydus Cadila

Contact Supplier

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Digital Content

Zydus inks pact with China Medical System to market Desidustat in Greater China

Details:

Under the terms and conditions of the agreement, CMS will be responsible for development, registration and commercialisation of Desidustat in Greater China.

Lead Product(s): Desidustat

Therapeutic Area: Hematology Product Name: Undisclosed

Highest Development Status: Phase III Product Type: Small molecule

Partner/Sponsor/Collaborator: Zydus Cadila

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement January 20, 2020

ASK
US

Upload
your Pipeline Activity

POST ENQUIRY